Miyuki Niimi

1.2k total citations
23 papers, 870 citations indexed

About

Miyuki Niimi is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Miyuki Niimi has authored 23 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Miyuki Niimi's work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Miyuki Niimi is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Miyuki Niimi collaborates with scholars based in Japan, United States and India. Miyuki Niimi's co-authors include Kenichi Yoshimura, Shu‐ichi Ikeda, Haruhiko Fukuda, Akira Shimizu, M Shimoyama, Kensei Tobinai, Masayuki Sano, Mitsutoshi Tara, Yasuaki Yamada and Kiyoshi Takatsuki and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and British Journal of Haematology.

In The Last Decade

Miyuki Niimi

23 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miyuki Niimi Japan	12	266	204	173	151	147	23	870
Masakazu Shimizu Japan	14	373 1.4×	51 0.3×	109 0.6×	142 0.9×	67 0.5×	25	1.0k
Toshiki Uchida Japan	26	277 1.0×	31 0.2×	122 0.7×	650 4.3×	130 0.9×	86	1.9k
Mitsuo Hori Japan	16	211 0.8×	35 0.2×	38 0.2×	562 3.7×	52 0.4×	43	1.1k
Ahmed Sawas United States	15	309 1.2×	32 0.2×	61 0.4×	487 3.2×	59 0.4×	68	1.0k
Berger Cl United States	12	390 1.5×	21 0.1×	38 0.2×	163 1.1×	119 0.8×	22	760
Maike Buettner Germany	21	467 1.8×	7 0.0×	64 0.4×	547 3.6×	26 0.2×	32	1.1k
Takumi Kumai Japan	20	895 3.4×	5 0.0×	87 0.5×	712 4.7×	71 0.5×	73	1.3k
Masako Ishiguro Japan	19	38 0.1×	11 0.1×	405 2.3×	204 1.4×	8 0.1×	51	821
Manabu Kawakami Japan	24	461 1.7×	5 0.0×	172 1.0×	447 3.0×	23 0.2×	50	1.8k
Xavier Lafarge France	14	602 2.3×	5 0.0×	70 0.4×	148 1.0×	30 0.2×	43	1.0k

Countries citing papers authored by Miyuki Niimi

Since Specialization

Citations

This map shows the geographic impact of Miyuki Niimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyuki Niimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyuki Niimi more than expected).

Fields of papers citing papers by Miyuki Niimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyuki Niimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyuki Niimi. The network helps show where Miyuki Niimi may publish in the future.

Co-authorship network of co-authors of Miyuki Niimi

This figure shows the co-authorship network connecting the top 25 collaborators of Miyuki Niimi. A scholar is included among the top collaborators of Miyuki Niimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyuki Niimi. Miyuki Niimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ogawa, Takahisa, Kazuyuki Fukushima, Miyuki Niimi, et al.. (2023). A Comparison of Spinopelvic Alignment and Quality of Life between Farmers and Non-Farmers: A Cross-Sectional Population-Based Study in a Japanese Rural Area. Journal of Clinical Medicine. 12(4). 1393–1393. 1 indexed citations

Kakushima, Naomi, Hiroyuki Ono, Takahiro Horimatsu, et al.. (2015). Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial. Journal of Gastroenterology. 51(2). 104–111. 9 indexed citations

Morimoto, Naoki, Kenichi Yoshimura, Miyuki Niimi, et al.. (2013). Novel Collagen/Gelatin Scaffold with Sustained Release of Basic Fibroblast Growth Factor: Clinical Trial for Chronic Skin Ulcers. Tissue Engineering Part A. 19(17-18). 1931–1940. 82 indexed citations

Sugie, Tomoharu, Terumasa Sawada, Nobumi Tagaya, et al.. (2013). Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer. Annals of Surgical Oncology. 20(7). 2213–2218. 123 indexed citations

Suzuki, M., Itaru Kato, Teruhito Aihara, et al.. (2013). Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. Journal of Radiation Research. 55(1). 146–153. 138 indexed citations

Nagai, Kengo, Manabu Muto, Yasumasa Ezoe, et al.. (2012). A phase I study of salvage photodynamic therapy (PDT) using talaporfin sodium and a diode laser for local failure of esophageal carcinoma (EC) after chemoradiotheapy (CRT).. Journal of Clinical Oncology. 30(4_suppl). 123–123. 1 indexed citations

Yano, Tomonori, Manabu Muto, Kenichi Yoshimura, et al.. (2012). Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer. Radiation Oncology. 7(1). 113–113. 64 indexed citations

Morimoto, Naoki, Kenichi Yoshimura, Miyuki Niimi, et al.. (2012). An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: a study protocol.. PubMed. 4(1). 52–9. 30 indexed citations

Nagai, Hiroki, Shiro Tanaka, Miyuki Niimi, et al.. (2011). Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan. International Journal of Clinical Oncology. 16(5). 560–567. 2 indexed citations

10.

Tanaka, Shiro, et al.. (2011). Design paper: A phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment (BEST). Trials. 12(1). 120–120. 11 indexed citations

11.

Ishiguro, Hiroshi, S Takashima, Kenichi Yoshimura, et al.. (2011). Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients. Supportive Care in Cancer. 20(9). 2017–2024. 17 indexed citations

12.

Kanai, Masashi, Akira Yoshioka, Shiro Tanaka, et al.. (2010). Associations between glutathione S-transferase π Ile105Val and glyoxylate aminotransferase Pro11Leu and Ile340Met polymorphisms and early-onset oxaliplatin-induced neuropathy. Cancer Epidemiology. 34(2). 189–193. 30 indexed citations

13.

Yanagihara, Kazuhiro, Kenichi Yoshimura, Miyuki Niimi, et al.. (2010). Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 66(5). 913–918. 12 indexed citations

14.

Itoh, Kuniaki, T. Ohtsu, Haruhiko Fukuda, et al.. (2002). Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505. Annals of Oncology. 13(9). 1347–1355. 44 indexed citations

15.

Niimi, Miyuki. (2002). The Influence of Handling Censored Data on Estimating Progression-free Survival in Cancer Clinical Trials (JCOG9913-A). Japanese Journal of Clinical Oncology. 32(1). 19–26. 5 indexed citations

16.

Yamada, Yasuaki, Masao Tomonaga, Haruhiko Fukuda, et al.. (2001). A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303. British Journal of Haematology. 113(2). 375–382. 264 indexed citations

17.

Takenaka, T, S Shirakawa, C Mikuni, et al.. (1999). Alternating Combination Chemotherapy COP (Cyclophosphamide, Vincristine, Prednisone) and MP (Melphalan, Prednisone) in Multiple Myeloma: a Multicenter Phase II Study (JCOG8906). Japanese Journal of Clinical Oncology. 29(10). 485–489. 3 indexed citations

18.

Miyanaga, Naoto, Hideyuki Akaza, Nobuo Shinohara, et al.. (1999). ASSESSMENT OF QOL AND SURVIVAL FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY OR BLADDER PRESERVATION FOR INVASIVE BLADDER CANCER. The Japanese Journal of Urology. 90(3). 445–453. 7 indexed citations

19.

Niimi, Miyuki, Hideyuki Akaza, Naoto Miyanaga, et al.. (1999). [Development of Japanese version of QOL questionnaire for bladder and prostate cancer patients using FACT-Bl and P: pilot study].. PubMed. 26(5). 657–66. 20 indexed citations

20.

Niimi, Miyuki, Hideyuki Akaza, Hitoshi Takeshima, et al.. (1997). THE PHYSICAL, MENTAL AND SOCIAL IMPACTS OF TELLING PROSTATE CANCER PATIENTS THE TRUE DIAGNOSIS. The Japanese Journal of Urology. 88(8). 752–761. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact